Retrospectively-collected specimens from biobanks often lack the information you need to maximize biomarker identification and validation, such as donor medical records, specific collection protocols, and viability metrics. Prospectively designing your own biobank circumvents these drawbacks and instills confidence in your translational research results.
Sanguine has extensive experience helping customers build their own biobanks, even those with multiple sample types (e.g., PBMCs and plasma) collected in a single visit. |